Another important evidence that we have obtained was expression of immune checkpoint inhibitor PD-L1 in both naïve and CR SCLC cells and augmented levels of PD-L1 were observed in CisR cell lines (supplementary Fig. S16). The gene discussed is CD274; the disease is small cell lung carcinoma.